Related Experiment Videos
P53 protein expression in Hodgkin's disease
A F Lauritzen1, K Hou-Jensen, E Ralfkiaer
1Department of Pathology, Herlev Hospital, Denmark.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|September 1, 1993
Summary
Mutations in the p53 tumor suppressor gene are common in human cancers. This study found p53 protein overexpression in most Hodgkin
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 gene acts as a tumor suppressor, crucial for preventing malignant transformation.
- p53 gene mutations are frequent in human cancers, leading to altered protein stability and overexpression.
- Normal p53 protein is typically unstable and undetectable by immunohistology, unlike its mutated counterpart.
Purpose of the Study:
- To investigate the presence and potential role of p53 protein in different subtypes of Hodgkin's disease.
- To determine the frequency of p53 protein expression in Hodgkin's and Reed-Sternberg cells.
Main Methods:
- Utilized a panel of four anti-p53 antibodies (PAb240, PAb421, PAb1801, and DO7).
- Analyzed 52 Hodgkin's disease cases, including nodular lymphocytic predominance (LP), nodular sclerosis (NS), and mixed cellularity (MC) subtypes.
- Applied immunohistochemistry to detect p53 protein expression in tumor cells.
Main Results:
- p53 protein was detected in Hodgkin's and Reed-Sternberg cells in 82% of nodular sclerosis (NS) cases.
- p53 protein was detected in 94% of mixed cellularity (MC) cases.
- No p53 protein expression was observed in nodular lymphocytic predominance (LP) cases.
Conclusions:
- Mutations in the p53 gene and subsequent loss of normal function are frequent in Hodgkin's disease, particularly in NS and MC subtypes.
- The findings suggest a potential role for p53 gene alterations in the pathogenesis of Hodgkin's disease.
- Further research is warranted to elucidate the precise mechanisms by which p53 dysfunction contributes to Hodgkin's lymphoma development.